Siemens Healthineers has completed the acquisition of Varian Medical Systems. The companies are building on a long-standing strategic partnership called EnVision to establish a comprehensive digital, diagnostic and therapeutic ecosystem that includes treatment management.
“With the completion of this transaction, we are now best positioned to take two leaps together: a leap in cancer care and a leap in our impact on healthcare overall,” commented Siemens Healthineers ceo Dr Bernd Montag. “Together, we are establishing a strong and trusted partner capable of supporting customers and patients along the entire cancer care continuum as well as through all major clinical pathways.”
The combined company is creating an integrated portfolio of imaging, laboratory diagnostics, AI and treatment for cancer. With Varian, Siemens will leverage AI-assisted analytics to advance the development and delivery of data-driven precision care. Through early and accurate detection as well as more efficient diagnosis, increased treatment quality and access, Siemens will support Varian’s mission to reduce uncertainty for cancer patients and increase the level of cancer survival.
Lead picture: Siemens Healthineers’ new headquarters in Erlangen, Germany
Published on page 6 of the June 2021 issue of RAD Magazine.